Efficacy outcomes of CDK4/6 inhibitors in combination with endocrine therapy treatment in hormone receptor-positive/HER2-negative advanced breast cancer according to PAM50 intrinsic subtype: Primary results of SOLTI-1801 CDK-PREDICT study

• DOI: 10.1016/j.ejca.2024.115219
• Publication Date: 2025-01-05T02:43:51Z
• Authors: Pablo Tolosa; Tomás Pascual; Olga Martínez-Saez; Cristina Hernando; Sonia Servitja; María Fernández Abad; Fara Brasó-Maristany; Ester Sanfeliu; Javier David Beni...; Laura Lema; Yolanda Ruano; Isabel García-Fru...; Lucía Parrilla; Adela Rodríguez; Ana María Roncero; María Ángeles Cobos; Rodrigo Sánchez-B...; Manuel Alva; Ainhoa Madariaga; Guillermo Villacampa; Jordi Canes; Fernando Salvador; Agustín Sánchez-B...; Marcos Malumbres; Aleix Prat; Eva Ciruelos